Company Overview and News
Larger and more financially healthy E&P companies are grouped together for analysis purposes in this "Tier One Producer" or "TOP Club"
CRC GDPMQ CHKVP PSX CRK QEP CHKVZ CRZO GDAOQ EGC EXXIQ SNZYP GDRRQ AMPY TALO SRCI EEXXQ BCEI RRS JONE WPX ESTE EXXI GDP CHK SGY TTEN MPOYQ SDRXP LINE SDRXQ APA HES DVN PVA EPE PIONF CHKDH CHKDG MCF CHKDJ ROSEU VNR CHKDP REI RSPP JNEEP AMR AMGP JAG ROSE LINEQ CKRGZ EVEP EOG RGRYY UPLMQ VNRCP PIO LNGG AR SWTF AM EXIXQ CHAP VNRBP SN XOG NBL WLL PDCE SM CTLR HKRCP SD RGRLF RRC DNR MPO VNRAP CLR GDPAN GDPAQ ECR CHPE UPL WPXP SDRPQ REN PE CXO RRL SCAZP AXAS COP AREX ECA SFY EVEPQ CDEV BRMR GDPM PVAYQ VNRR ECA SBOW CHKWZ GDUEQ SDOCQ GDANQ CHK.WI PVAC LPI WES HK HPR BRY
De Grey Mining Ltd (ASX:DEG) will begin testing what could be more conglomerate gold nuggets from its Pilbara Gold Project 80 kilometres southwest of Port Hedland.
DEG PIO KGI NSRPF NEM KGI.DB.A KGI.DB NVO PIONF KL
For years trusts like BPT have offered exposure to rising commodity prices in a high-yield vehicle; however, many publicly traded trusts are nearing the end of their finite lifespans.
PIO XOM LNGG CHKVP CXO PIONF CHKDH CHKVZ XTO CHKDG CHKDJ VNR CHKDP VNRBP LINEQ CKRGZ NBL BSM VNRR CHKWZ BPT CHK.WI CHK VNRAP VNRCP LINE
2018-09-24 seekingalpha - 1
Lithium China spot prices down again, as global contract prices rise. The gap has now narrowed.
LIT BCN PIO PILBF LTHHF CXO SAV 500008 BNPQY LAXXF LIACF AGY BAR NMT ARJQY PLLLY RDRUY AZZVF MS WML SQM MLNLF AIS.H KDR SYA STLHF WMLLF LNRDY NGZ AMVMF BNPZY LMMFF GXY LRS MNIKF ILHMF AMLM ALB GFI.WI DMNXF MALRY BGS LACDF EEYMF PIONF MIN NMKEF ARYMF AMARAJABAT ILC GALXF MGXMF LSSCF ALTAF DJIFF NMX EMH PSC CRECF OROCF GFIOF ERPNF LAC PLS BNPQF BCN DJI RRSSF PDDTF NTTHF GFI MALRF ORE AVZ AJM BCRMF
2018-09-24 seekingalpha - 1
Cobalt spot prices were slightly down in September but appear to have stabilized just below US$30/lb.
SIE PIO CLA PANRF CCZ PAN HAV MCR KBGCF CTM AXE ECSIF IGO VIC AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR JRV SHERF CDU RGARF CHK MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE MALRY HBNRF MEI PIONF BPLNF GAL CZI AMSLF HMI MIN POS AUZ RNX GME FQVLF AQR PTNUF WCTXD FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM CNJ AZRMF HLPCF BPL BHP OZL MALRF ARV
VANCOUVER, British Columbia, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has finalised the transaction with Pioneer Resources Limited (“Pioneer”) as described in the Company’s news release dated September 17, 2018. Completion of the transaction was subsect to TSX Venture Exchange approval which has been obtained.
PIO NSRPF NVO PIONF
Novo Resources Corp of Canada (TSX-V:NVO) (CVE:NVO) (FRA:1NO) (OTCMKTS:NSRPF) will snap up De Grey Mining Limited’s (ASX:DEG) joint venture partner in the Egina district of Western Australia’s Pilbara region for $8 million, in a cash-and-scrip deal with Farno McMahon Pty Ltd and its shareholders.
DEG PIO KGI NSRPF NEM KGI.DB.A KGI.DB NVO PIONF KL
Novo Resources is to secure 100 per cent of Farno-McMahon (Farno) and enter a farm-in to earn the right to up to 70 per cent of the Kangan gold project in separate deals with Farno and Pioneer Resources.
PIO DEG NSRPF NVO PIONF
2018-09-04 seekingalpha - 1
The 18 remaining companies in the Bottom of the Barrel Club recently reported 2Q results that were largely underwhelming overall.
ECR CRC APC PIO LGCYP LGCYO CRK DVN EPE SCAZP PIONF AXAS XTO MCEP ACTPF AREX MHRC EGC RXNRP REXXQ JNEEP SNZYP AST SN JGPK TALO BRMR SRCI MAGH JONE EOG DNR REXX BBG CHK CVX SGY LGCY HPR BRY AEUA
Prominent mining commentator Allan Trench believes corporate decision makers in the mining industry aren’t paying heed to the lessons of Australia’s boom and bust cycle.
PIO ENT PIONF
Cobalt miner news - BHP seeking to add cobalt sulphate from Nickel West operation. China Molybdenum net profit set to surge between 271.21% and 295.16%.
SIE PIO CLA PANRF BLT CCZ PAN HAV MCR KBGCF CTM AXE ECSIF IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR CDU RGARF CHK MCRZY FTMDF KAT RER BBL CSSQF BHPLF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF GAL CZI AMSLF BPLNF HMI POS AUZ RNX GME FQVLF AQR PTNUF FT BHPBF HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM BHP CNJ AZRMF HLPCF BPL BHP OZL ARV
Pioneer Resources Ltd (ASX:PIO) has confirmed a market-significant volume of potassium feldspar directly above the Sinclair caesium deposit at its Pioneer Dome project in Western Australia.
2018-07-25 proactiveinvestors.com.au - 1
Pioneer Resources Ltd (ASX:PIO) has received approval for its mining proposal at the Sinclair Zone caesium deposit within its Pioneer Dome project in Western Australia’s Eastern Goldfields.
PIO CBT EGS PIONF EGDD ESGFF
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
as of ET